NEWS BRIEFING and EXPERT REACTION: Retraining the brain for chronic pain
Embargoed until:
Publicly released:
2025-05-07 01:00
******BRIEFING RECORDING AVAILABLE******* Retraining the brain to better process emotions could be an effective therapy for chronic pain, according to Aussie researchers. The randomised controlled trial focused on the experiences of 89 people with chronic pain, and included a therapy which aimed to improve the patients' ability to deescalate negative emotions and enhance positive ones. Those who received the new treatment reported better emotional regulation, as well as pain reduction within a six-month follow-up. Tune into our online briefing to hear from the lead authors of the study, as well as a trial participant who will be available during the Q&A session.
Journal/conference: JAMA Network Open
Research: Paper
Organisation/s: The University of New South Wales, The University of Adelaide, University of Technology Sydney (UTS)
Funder: Funding/Support: This work was supported by the Rebecca L. Cooper Medical Research Foundation and grant 2027056 from the MRFF (Prof Gustin). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Conflict of Interest Disclosures: Ms Norman-Nott reported receiving grants from the Australian Commonwealth Government Research Training Program and Neuroscience Research Australia during the conduct of the study. Dr Briggs reported receiving grants from the Cystic Fibrosis Foundation outside the submitted work. Dr Diwan reported receiving grants from Globus Medical-Nuvasive and research funding from Baxter Philanthropy outside the submitted work. Dr Suh reported being employed by Microsoft Research during the conduct of the study. Dr Newby reported receiving grants from the National Health and Medical Research Council (NHMRC) of Australia during the conduct of the study and grants from the National Institute for health and Care Research, KONESKI, Wellcome Trust, and Medical Research Fund Future (MRFF) outside the submitted work. Prof McAuley reported receiving grants from the NHMRC of Australia during the conduct of the study and grants from MRFF outside the submitted work. Prof Gustin reported receiving grants from the NHMRC of Australia, MRFF, New South Wales Health, Wings for Life, and the US Department of Defense during the conduct of the study. No other disclosures were reported.
Media release
From: Australian Science Media Centre
Date: Mon 05 May 2025
Start Time: 10:00am AEST
Duration: Approx 45 min
Venue: Online - Zoom
Speakers:
- Professor Sylvia Gustin is the Director of the Neurorecovery Research Hub, University of New South Wales and Director of the Centre for Pain IMPACT, Neuroscience Research Australia
- Dr Nell Norman-Nott is Research Fellow & Clinical Trial Manager at the University of New South Wales and Neuroscience Research Australia
Briefings are free to attend, but if you like what we do, you can donate to the Australian Science Media Centre here
Attachments:
Note: Not all attachments are visible to the general public
-
JAMA
Web page
-
Australian Science Media Centre
Web page
-
The University of New South Wales
Web page
Expert Reaction
These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.
Professor Lorimer Moseley AO is a Bradley Distinguished Professor, Foundation Chair in Physiotherapy at UniSA, Chair of PainAdelaide and Founder and CEO of the non-profit Pain Revolution